Genevant is a technology-focused nucleic acid delivery company with world-class platforms, the industry’s most robust and expansive lipid nanoparticle (LNP) patent estate and decades of expertise in nucleic acid drug development. They leverage world-class delivery systems and related technologies to bring new medicines to patients who need them. Genevant does this by selectively collaborating with leading pharma and biotech companies and fostering a culture of innovation that allows them to maintain our leadership position in the space. 

Biotechnology

Genevant Sciences

Pete Lutwyche

Gregg Ashby

James Heyes

Pete Zorn

Ed Yaworski

Tracy Meffen

Scientific Development

Leadership Team

Genevant Sciences

Org chart

Teams

Scientific Development

Leadership Team

Similar companies